Literature DB >> 7251164

Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus.

J H Bowdre, M D Poole, J D Oliver.   

Abstract

Vibrio vulnificus (lactose-positive Vibrio), a recently recognized pathogenic marine species, produced extreme hemoconcentration and death within 3 to 6 h after subcutaneous or intraperitoneal injection of 10(8) viable cells into mice; hemotocrit values approached 70% (normal, 45%). About 1 ml of edema fluid accumulated at the site of each subcutaneous injection, and locally increased vascular permeability was demonstrated by a skin bluing assay, using Evans blue dye. A corresponding fluid accumulation did not occur in the peritoneal cavity after an intraperitoneal injection. Filter-sterilized supernatants of cultures grown under a variety of conditions did not produce local edema or lethality, nor did whole Vibrio cells killed by a variety of methods or disrupted by sonic oscillation. Edema fluids collected from infected mice and sterilized by filtration had no effect when they were injected subcutaneously or intraperitoneally into mice. Inocula of 10(9) viable cells of V. vulnificus contained within a diffusion chamber implanted subcutaneously did not produce skin bluing, edema, or lethality; Vibrio cells remained viable and virulent within these chambers for at least 2 weeks. These experiments suggested that vascular permeability changes in V. vulnificus infections may not be attributable to a diffusible toxin and may require direct contact between host cells and viable Vibrio cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251164      PMCID: PMC351578          DOI: 10.1128/iai.32.3.1193-1199.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Collagenolytic activity of some marine bacteria.

Authors:  J R Merkel; J H Dreisbach; H B Ziegler
Journal:  Appl Microbiol       Date:  1975-02

2.  Implantation and use of a subcutaneous culture chamber in laboratory animals.

Authors:  R J Arko
Journal:  Lab Anim Sci       Date:  1973-02

3.  Neuraminidase and N-acetylneuraminate pyruvate-lyase of Pasteurella multocida.

Authors:  R Drzeniek; W Scharmann; E Balke
Journal:  J Gen Microbiol       Date:  1972-09

4.  Leg gangrene and endotoxin shock due to vibrio parahaemolyticus--an infection acquired in New England coastal waters.

Authors:  F P Roland
Journal:  N Engl J Med       Date:  1970-06-04       Impact factor: 91.245

5.  More pathogenic vibrios.

Authors:  C C Carpenter
Journal:  N Engl J Med       Date:  1979-01-04       Impact factor: 91.245

6.  Study of genetic relationships among marine species of the genera Beneckea and Photobacterium by means of in vitro DNA/DNA hybridization.

Authors:  J L Reichelt; P Baumann; L Baumann
Journal:  Arch Microbiol       Date:  1976-10-11       Impact factor: 2.552

7.  Halophilic Vibrio species isolated from blood cultures.

Authors:  D G Hollis; R E Weaver; C N Baker; C Thornsberry
Journal:  J Clin Microbiol       Date:  1976-04       Impact factor: 5.948

8.  Taxonomy of marine bacteria: Beneckea parahaemolytica and Beneckea alginolytica.

Authors:  P Baumann; L Baumann; J L Reichelt
Journal:  J Bacteriol       Date:  1973-03       Impact factor: 3.490

9.  Evidence of a role for permeability factors in the pathogenesis of salmonellosis.

Authors:  J W Peterson; P D Sandefur
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

10.  Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp.

Authors:  M D Poole; J D Oliver
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

View more
  22 in total

Review 1.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

2.  Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.

Authors:  A M Starks; T R Schoeb; M L Tamplin; S Parveen; T J Doyle; P E Bomeisl; G M Escudero; P A Gulig
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus.

Authors:  S Yoshida; M Ogawa; Y Mizuguchi
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

4.  Detection of anti-Vibrio vulnificus cytolysin antibodies in sera from mice and a human surviving V. vulnificus disease.

Authors:  L D Gray; A S Kreger
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

5.  Collagenolytic activity of Vibrio vulnificus: potential contribution to its invasiveness.

Authors:  G C Smith; J R Merkel
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera.

Authors:  A S Kreger; L D Gray; J Testa
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species.

Authors:  M L Tamplin; S Specter; G E Rodrick; H Friedman
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

8.  Distribution and ecology of Vibrio vulnificus and other lactose-fermenting marine vibrios in coastal waters of the southeastern United States.

Authors:  J D Oliver; R A Warner; D R Cleland
Journal:  Appl Environ Microbiol       Date:  1982-12       Impact factor: 4.792

9.  Marker exchange mutagenesis of the aerolysin determinant in Aeromonas hydrophila demonstrates the role of aerolysin in A. hydrophila-associated systemic infections.

Authors:  T Chakraborty; B Huhle; H Hof; H Bergbauer; W Goebel
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

10.  Comparative studies and laboratory diagnosis of Vibrio vulnificus, an invasive Vibrio sp.

Authors:  E P Desmond; J M Janda; F I Adams; E J Bottone
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.